Demo Sign up Log In

Aprea Therapeutics, Inc. (APRE)

EV to Operating Cash Flow

2.85×

TTM · Retrieved: Oct 24, 2026

APRE EV to Operating Cash Flow

Current (TTM)2.85×retrievedOct 24, 2026

Current (TTM)2.85×retrievedOct 24, 2026

APRE Quarterly EV/OCF (0.00× → -0.51×)

Latest values, visible window

High-resolution chart · PNG

APRE ev to operating cash flow history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. EV to Operating Cash Flow — Quarterly
Period ending	EV to Operating Cash Flow
Jun 30, 2026	-0.5113×
Mar 31, 2026	12.7915×
Dec 31, 2025	2.7155×
Sep 30, 2025	1.3516×
Jun 30, 2025	1.9968×
Mar 31, 2025	1.941×
Dec 31, 2024	0.9282×
Sep 30, 2024	4.0171×
Jun 30, 2024	1.3091×
Mar 31, 2024	1.4509×
Dec 31, 2023	1.0815×
Sep 30, 2023	4.3671×
Jun 30, 2023	4.9522×
Mar 31, 2023	4.8429×
Dec 31, 2022	1.0157×
Sep 30, 2022	1.589×
Jun 30, 2022	2.4574×
Mar 31, 2022	1.2133×
Dec 31, 2021	-0.8774×
Sep 30, 2021	-5.7472×
Jun 30, 2021	-4.3586×
Mar 31, 2021	-2.6641×
Dec 31, 2020	-1.1786×
Sep 30, 2020	-31.0823×
Jun 30, 2020	-73.2594×
Mar 31, 2020	-80.8506×
Dec 31, 2019	-76.9793×
Sep 30, 2019	-55.4688×
Jun 30, 2019	-59.4814×
Mar 31, 2019	0×
Dec 31, 2018	-57.8706×
Sep 30, 2018	0×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.